Quest PharmaTech Inc.

OTC: QPTFF · Healthcare · Biotechnology

Canadian filerHQ Edmonton, ABReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 75DQ —GM —SS 30

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ workforce scale, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

$3.6M

Employees

Market cap

$5.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income$3.6M5.0M CAD2025

Operating income-$511.5k-712.4k CAD2025

Total assets$20.5M27.8M CAD2025

Liabilities$981.3k1.3M CAD2025

Equity$19.5M26.5M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Quest PharmaTech Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.

Peers · Healthcare

Alaunos Therapeutics, Inc.33D NextCure, Inc.37D GT Biopharma, Inc.32D Unidoc Health Corp.——

Key facts

CEORagupathy Madiyalakan

SectorHealthcare

IndustryBiotechnology

HeadquartersEdmonton, AB

ExchangeOTC: QPTFF

Employees3

IPO date2018-08-24

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.